Skip to main content
Journal ArticleOPEN ACCESS

Methylprednisolone therapy in multiple sclerosis: A profile of adverse effects

Journal of Neurology Neurosurgery and Psychiatry (1988) 51(2) 285-287
DOI: 10.1136/jnnp.51.2.285
84Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

A restrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

Cite

CITATION STYLE

APA

Lyons, P. R., Newman, P. K., & Saunders, M. (1988). Methylprednisolone therapy in multiple sclerosis: A profile of adverse effects. Journal of Neurology Neurosurgery and Psychiatry, 51(2), 285–287. https://doi.org/10.1136/jnnp.51.2.285

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free